4CPS-060 Effectiveness and economic analysis of weight-based versus fixed dosing of pembrolizumab in non -mall cell lung cancer

Autor:	J Ibanez-Caturla, P Torrano-Belmonte, L Fructuoso-González, JA Gutiérrez Sánchez, P Pacheco López, MÁ Carvajal Sánchez, M Guillén Díaz, A Martínez Orea, J León Villar, JC Titos Arcos
Rok vydání:	2023
Zdroj:	Section 4: Clinical pharmacy services.
DOI:	10.1136/ejhpharm-2023-eahp.92
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::654bb188e5ae0a5f188e7141a3a5c30e https://doi.org/10.1136/ejhpharm-2023-eahp.92 Zobrazit plný text záznamu